Sound wave therapy plus chemo for advanced pancreatic cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new treatment that uses sound waves to help chemotherapy reach pancreatic tumors more effectively. It is for people with locally advanced pancreatic cancer that cannot be removed with surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have locally advanced pancreatic cancer that cannot be removed with surgery yet.
- Your doctor says you can safely have the chemotherapy combination mFOLFIRINOX.
- You have not had any prior chemotherapy, surgery, or radiation for your pancreatic cancer.
- You may have had a procedure to bypass a blocked bile duct or a stent placed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining targeted radiation with an at-home “tumor treating fields” device can better control locally advanced pancreatic cancer. It may help by attacking cancer cells in more than one way after prior chemotherapy.
This trial tests a new non-invasive treatment that uses sound waves to break up cancer cells in the pancreas. It is for people whose pancreatic cancer cannot be removed by surgery and who are well enough for anesthesia.
This trial tests a new device that uses sound waves (histotripsy) to break apart pancreatic tumors without surgery. It is for people with advanced pancreatic cancer that cannot be removed and who have already had chemotherapy. The goal is to see if this treatment can help control the tumor.
This trial tests a new treatment that uses ultrasound to help chemotherapy reach liver tumors in people with advanced pancreatic cancer. It may help shrink tumors and improve how well the chemotherapy works.
This trial studies whether adding focused ultrasound (a treatment that uses sound waves to target the tumor) to standard chemotherapy can help shrink or control pancreatic cancer in people whose cancer is borderline resectable or locally advanced. It aims to see if this combination is more effective than chemotherapy alone.
This trial combines two treatments for advanced pancreatic cancer that hasn't spread: a special endoscopic procedure that uses heat to destroy cancer cells (radiofrequency ablation) and a standard chemotherapy drug combination (FOLFIRINOX). The goal is to see if this combination is safe and can help control the tumor better than chemotherapy alone.
Hear when a new Locally Advanced Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.